Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5078963
Max Phase: Preclinical
Molecular Formula: C22H35NO32S4
Molecular Weight: 953.77
Molecule Type: Unknown
Associated Items:
ID: ALA5078963
Max Phase: Preclinical
Molecular Formula: C22H35NO32S4
Molecular Weight: 953.77
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCOCCO[C@@H]1O[C@@H](C(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@@H]3O[C@@H](C(=O)O)[C@@H](OS(=O)(=O)O)[C@H](O)[C@H]3OS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)[C@H](O)[C@H]1OS(=O)(=O)O
Standard InChI: InChI=1S/C22H35NO32S4/c23-1-2-45-3-4-46-20-11(53-57(36,37)38)5(24)8(14(49-20)17(27)28)47-21-12(54-58(39,40)41)6(25)9(15(50-21)18(29)30)48-22-13(55-59(42,43)44)7(26)10(52-56(33,34)35)16(51-22)19(31)32/h5-16,20-22,24-26H,1-4,23H2,(H,27,28)(H,29,30)(H,31,32)(H,33,34,35)(H,36,37,38)(H,39,40,41)(H,42,43,44)/t5-,6-,7-,8-,9-,10-,11+,12+,13+,14+,15+,16+,20+,21+,22+/m0/s1
Standard InChI Key: ZQYMTEZMYWSEJB-BQQTZKQXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 953.77 | Molecular Weight (Monoisotopic): 953.0025 | AlogP: -7.99 | #Rotatable Bonds: 21 |
Polar Surface Area: 517.62 | Molecular Species: ZWITTERION | HBA: 26 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 33 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -2.82 | CX Basic pKa: 9.45 | CX LogP: -12.09 | CX LogD: -24.28 |
Aromatic Rings: 0 | Heavy Atoms: 59 | QED Weighted: 0.04 | Np Likeness Score: 0.64 |
1. Shanthamurthy CD, Leviatan Ben-Arye S, Kumar NV, Yehuda S, Amon R, Woods RJ, Padler-Karavani V, Kikkeri R.. (2021) Heparan Sulfate Mimetics Differentially Affect Homologous Chemokines and Attenuate Cancer Development., 64 (6.0): [PMID:33683903] [10.1021/acs.jmedchem.0c01800] |
Source(1):